Potential New Drugs for Endometriosis: Experimental Evidence

Kaei Nasu, Yukie Kawano, Masakazu Nishida, Akitoshi Tsuno, Akitoshi Yuge, Wakana Abe, Kentaro Kai, Mamiko Okamoto, Hisasshi Narahara
In: Endometriosis · 2014 · pp. 235–249 · doi:10.1007/978-4-431-54421-0_16 · W148452588
book-chapter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06+body, 2026-06-07 ⓘ

This review discusses the pathogenesis of endometriosis and evaluates novel medical treatments, focusing on inhibitors of NF-κB, the mevalonate-Rho/ROCK pathway, and histone deacetylase as promising therapeutic agents.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 ⓘ

This chapter/review assesses basic-pathogenesis findings in endometriosis and evaluates novel candidate therapies, emphasizing inhibitors of nuclear factor-κB, the mevalonate-Rho/ROCK pathway, and histone deacetylase, drawing on mechanistic studies of apoptosis, fibrosis, and epigenetic dysregulation in affected women. It describes how current hormonal approaches that lower estradiol have limited use due to unacceptable side effects and frames new molecular-targeted or herbal strategies—including these pathway inhibitors—as promising for treatment and prevention. A limitation is that the article is a synthesis of basic research rather than a single new experimental study, so it does not provide uniform clinical validation within the chapter itself. This paper is centrally about endometriosis — it reviews experimental evidence for new drug strategies targeting NF-κB, mevalonate-Rho/ROCK, and histone deacetylase in the disease’s apoptosis- and fibrosis-related mechanisms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK